In 1956 Sabin described attenuated poliovirus strains of each serological type selected by passage in monkeykidney cultures and segregated by plaque purification. Oral vaccines have been prepa.red from these strains in many countries and have been used extensively in a variety of epidemiological conditions (Brit. med. J., 1961). There have, however, been few reports of the use in Britain of the Sabin vaccines. Vaccination of a small number of children with the type 3 vaccine was described by Clarke et al. (1958), and a Medical Research Council investigation among young children, using all three types, was begun in 1960 (Brit. med. J., 1960 Neutralizing antibodies in the sera collected from the participants before and after vaccination were titrated simultaneously by the colour test (Shand, 1961), using a range of twofold dilutions from 1/4 to 1/2,048. Titres are expressed as the reciprocal of the final dilution of the serum in the virus-serum mixture. A titre of less than 4 was recorded as no antibody.
Virus solationsFaecal samples were brought to the laboratory by each participant within 12 hours of collection. Within two hours of receipt, extracts of the samples (approximately 10%) were made in tissue-culture medium containing extra antibiotics by homogenization and lowspeed centrifugation. Two tubes of monkey-kidney cultures were each inoculated with 0.5 ml. of extract. These cultures, already containing 1.5 ml. of medium, were left at room temperature for one hour; they were then emptied, washed once, and, after the addition of 2 ml. of fresh medium, incubated at 36.5°C. in a roller apparatus. The liquid phase of the cultures was harvested after seven days in the case of negative specimens, for passage to other cultures, or earlier in the event of the cytopathic effect of poliovirus, for serological typing. All strains isolated were serologically identified, either by complement-fixation test (Le Bouvier et al., 1954) or, when the test proved unsuccessful, by neutralization.The type 1 strains were also tested by a modification of the neutralization test capable of detecting minor antigenic differences between type 1 strains and of distinguishing the vaccine strain (LSc) as a subtype (Goffe and Shand, 1961).Results Pre-vaccination Antibodies.-Thirty-five sera taken before vaccination were examined; six had no antibody to type 1 virus, seven had none to type 2, and four had none to type 3. Twenty-four had antibodies to all three virus types and two were triple-negative. The distribution of antibody according to the history of vaccination with inactivated vaccine is given in Table I.